UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028908
Receipt number R000033070
Scientific Title Development studies of electronic patient's diary to improve pharmacist's CINV countermeasure (pre-trial)
Date of disclosure of the study information 2017/08/30
Last modified on 2020/06/10 14:12:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development studies of electronic patient's diary to improve pharmacist's CINV countermeasure (pre-trial)

Acronym

Development studies of electronic patient's diary to improve pharmacist's CINV countermeasure (pre-trial)

Scientific Title

Development studies of electronic patient's diary to improve pharmacist's CINV countermeasure (pre-trial)

Scientific Title:Acronym

Development studies of electronic patient's diary to improve pharmacist's CINV countermeasure (pre-trial)

Region

Japan


Condition

Condition

CINV chemotherapy induced nausea and vomiting

Classification by specialty

Not applicable

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To make clear the feeling of use of electronic patient's diary and CINV pharmaceutical management system to make it useful for system improvement

Basic objectives2

Others

Basic objectives -Others

Use feeling of electronic patient diary

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of electronic patient's diary

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Have the CINV symptom input for 7 days by using electronic patient's diary

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.patients undergoing hospitalization or outpatient chemotherapy
2.Patient who is 20 years old or more and can enter smartphone or personal computer
3.Patient who signed, based on his/her free will, to the clinical trial agreement with full understanding of the purpose of this conducted trial and its insights

Key exclusion criteria

1.Patients who may cause substrate or functional nausea / vomiting such as gastrointestinal transit disorder, brain metastasis, electrolyte abnormality, uremia, etc.
2.patients using emetic drugs in combination
3.patients taking antipsychotics with antiemetic actions, antiemetics and steroids on a regular basis
4.pregnant
5.judged by the investigator to be inappropriate for this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masayo
Middle name
Last name Komoda

Organization

Tokyo University of Science

Division name

Faculty of Pharmaceutical Sciences

Zip code

278-8510

Address

2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan

TEL

04-7121-4134

Email

komo1207@rs.noda.tus.ac.jp


Public contact

Name of contact person

1st name Masayo
Middle name
Last name Komoda

Organization

Tokyo University of Science

Division name

Faculty of Pharmaceutical Sciences

Zip code

278-8510

Address

2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan

TEL

04-7121-4134

Homepage URL


Email

komo1207@rs.noda.tus.ac.jp


Sponsor or person

Institute

Tokyo University of Science

Institute

Department

Personal name



Funding Source

Organization

Tokyo University of Science

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo University of Science

Address

2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan

Tel

0471214134

Email

komo1207@rs.noda.tus.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 08 Month 30 Day

Date of IRB

2017 Year 09 Month 10 Day

Anticipated trial start date

2017 Year 09 Month 10 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 03 Month 31 Day

Date trial data considered complete

2020 Year 03 Month 31 Day

Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 08 Month 30 Day

Last modified on

2020 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033070


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name